Found: 19
Select item for more details and to access through your institution.
The Pseudomonas syringae type III-secreted protein HopPtoD2 possesses protein tyrosine phosphatase activity and suppresses programmed cell death in plants.
- Published in:
- Molecular Microbiology, 2003, v. 49, n. 2, p. 377, doi. 10.1046/j.1365-2958.2003.03588.x
- By:
- Publication type:
- Article
The ShcA protein is a molecular chaperone that assists in the secretion of the HopPsyA effector from the type III (Hrp) protein secretion system of Pseudomonas syringae.
- Published in:
- Molecular Microbiology, 2002, v. 44, n. 6, p. 1469, doi. 10.1046/j.1365-2958.2002.02979.x
- By:
- Publication type:
- Article
Real-World Outcomes of Atezolizumab with Bevacizumab Treatment in Hepatocellular Carcinoma Patients: Effectiveness, Esophagogastroduodenoscopy Utilization and Bleeding Complications.
- Published in:
- Cancers, 2024, v. 16, n. 16, p. 2878, doi. 10.3390/cancers16162878
- By:
- Publication type:
- Article
Oncology education for family medicine residents: a national needs assessment survey.
- Published in:
- BMC Medical Education, 2020, v. 20, n. 1, p. N.PAG, doi. 10.1186/s12909-020-02207-0
- By:
- Publication type:
- Article
Outcomes of hepatocellular carcinoma patients treated in the lenvatinib and immunotherapy era (2018–2021) compared to the sorafenib era (2008–2018).
- Published in:
- Cancer Medicine, 2024, v. 13, n. 13, p. 1, doi. 10.1002/cam4.7415
- By:
- Publication type:
- Article
Effect of sorafenib starting dose and dose intensity on survival in patients with hepatocellular carcinoma: Results from a Canadian Multicenter Database.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 14, p. 4918, doi. 10.1002/cam4.3228
- By:
- Publication type:
- Article
Second‐line treatment of hepatocellular carcinoma after sorafenib: Characterizing treatments used over the past 10 years and real‐world eligibility for cabozantinib, regorafenib, and ramucirumab.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 13, p. 4640, doi. 10.1002/cam4.3116
- By:
- Publication type:
- Article
Prognosis of patients with hepatocellular carcinoma treated with sorafenib: a comparison of five models in a large Canadian database.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 7, p. 2816, doi. 10.1002/cam4.1493
- By:
- Publication type:
- Article
Randomised, Phase II study of selumetinib, an oral inhibitor of MEK, in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Structural analysis of H1N1 and H7N9 influenza A virus PA in the absence of PB1.
- Published in:
- Scientific Reports, 2014, p. 1, doi. 10.1038/srep05944
- By:
- Publication type:
- Article
Drug development for breast, colorectal, and non-small cell lung cancers from 1979 to 2014.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Developing Canadian oncology education goals and objectives for medical students: a national modified Delphi study.
- Published in:
- CMAJ Open, 2016, v. 4, n. 3, p. E359, doi. 10.9778/cmajo.20150127
- By:
- Publication type:
- Article
The prokaryotic enzyme DsbB may share key structural features with eukaryotic disulfide bond forming oxidoreductases.
- Published in:
- Protein Science: A Publication of the Protein Society, 2005, v. 14, n. 6, p. 1630, doi. 10.1110/ps.051355705
- By:
- Publication type:
- Article
Dosing, efficacy and safety of lenvatinb in the real‐world treatment of hepatocellular carcinoma: Results from a Canadian database.
- Published in:
- Liver Cancer International, 2022, v. 3, n. 3, p. 119, doi. 10.1002/lci2.59
- By:
- Publication type:
- Article
Optimizing Survival and the Changing Landscape of Targeted Therapy for Intermediate and Advanced Hepatocellular Carcinoma: A Systematic Review.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Impact of NAFLD on clinical outcomes in hepatocellular carcinoma treated with sorafenib: an international cohort study.
- Published in:
- Therapeutic Advances in Gastroenterology, 2022, v. 15, p. 1, doi. 10.1177/17562848221100106
- By:
- Publication type:
- Article
A Practical Guide for the Systemic Treatment of Biliary Tract Cancer in Canada.
- Published in:
- Current Oncology, 2023, v. 30, n. 8, p. 7132, doi. 10.3390/curroncol30080517
- By:
- Publication type:
- Article
Emerging Systemic Therapies in Advanced Unresectable Biliary Tract Cancer: Review and Canadian Perspective †.
- Published in:
- Current Oncology, 2022, v. 29, n. 10, p. 7072, doi. 10.3390/curroncol29100555
- By:
- Publication type:
- Article
Frequency, type and clinical importance of medication history errors at admission to hospital: a systematic review.
- Published in:
- Canadian Medical Association Journal (CMAJ), 2005, v. 173, n. 5, p. 510, doi. 10.1503/cmaj.045311
- By:
- Publication type:
- Article